Cardiff Oncology
CRDF----
Cardiff Oncology (CRDF)
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead dru...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Cardiff Oncology Analyst Rating
View MoreForecast & Rating
Jun 22, 2026Price forecast
$5.21522.16%
Forecast & RatingBuy
8analysts
- Strong buy37.50%
- Buy12.50%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 19 at 04:13 AM
From AI Pivots to Reverse Splits: U.S. Micro-Caps Embrace Aggressive Restructuring in July
- benzinga_article · Jul 15 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga_article · Jul 15 at 11:03 AM
Crude Oil Moves Lower; US Producer Prices Fall 0.3% In June
- benzinga_article · Jul 15 at 07:05 AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- PUBT · Jul 15 at 07:02 AM
Cardiff Oncology issues warrants to buy 9,303,136 shares in registered direct offering
- PUBT · Jun 22 at 08:00 AM
Cardiff Oncology CEO Mani Mohindru acquires 24,703 common shares for $29,890.63
